By Maggie Fick, Bhanvi Satija and Mariam Sunny LONDON, Feb 2 (Reuters) - The long-held Wall Street expectation that the ...

Lilly CEO Dave Ricks is confident in the ability of the company's pill to compete and is preparing for a "full launch" in the ...

As doctors learn why GLP-1s don't work for about 50% of people, they are also learning more about the complex drivers of ...

Using data culled from nearly 11 million people, the researchers found that just over 19% were obese in 1990, compared to ...

Researchers reviewed the body mass index of over 11 million Americans.

Rising rates of overweight and obese active-duty service members require a call to action across the entire military, one ...

The prevalence of obese adults in the United States more than doubled between 1990 and 2022.

Higher rates of death among younger Australians from cardiovascular disease has been linked to being overweight or obese, a ...

CNBC spoke to executives from Eli Lilly, Novo Nordisk, Pfizer and other drugmakers at the annual JPMorgan Healthcare ...

BERLIN, Jan 27 (Reuters) - Roche's experimental obesity drug, which works in a similar way to Eli Lilly's Zepbound, produced ...

Scientists may have found a new way to spot early signs of obesity, which could lead to novel prevention strategies. A study ...

Is Obesity Genetic or Environmental? Get All the Details This article was reviewed by Lynn Marie Morski, MD, JD. Key ...